Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4933]

Investigational magnetic device shrinks glioblastoma in first-in-world human test

Investigational magnetic device shrinks glioblastoma in first-in-world human test

FDA grants regular approval to pembrolizumab and lenvatinib for advanced endometrial carcinoma

FDA grants regular approval to pembrolizumab and lenvatinib for advanced endometrial carcinoma

Studies find combination chemotherapy beneficial and cost-effective in sub-Saharan Africa

Studies find combination chemotherapy beneficial and cost-effective in sub-Saharan Africa

Ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia

Ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia

New approach eradicates breast cancer in mice

New approach eradicates breast cancer in mice

Study identifies MET amplification as driver for some non-small cell lung cancers

Study identifies MET amplification as driver for some non-small cell lung cancers

Scientists identify protein markers related to the most common form of leukaemia

Scientists identify protein markers related to the most common form of leukaemia

CNIO researchers clarify the role of the two isoforms of KRAS, the most common oncogene in humans

CNIO researchers clarify the role of the two isoforms of KRAS, the most common oncogene in humans

New research could keep cancer-fighting T cells from burning out before the job is done

New research could keep cancer-fighting T cells from burning out before the job is done

Patients actively undergoing cancer treatment found to respond positively to the Pfizer COVID vaccine

Patients actively undergoing cancer treatment found to respond positively to the Pfizer COVID vaccine

More from ecancer